Retectix, LLC
Retectix, LLC is a medical device company producing nanofabricated surgical meshes offering superior handling and improved clinical outcomes
- Stage Full Product Ready
- Industry Biotechnology
- Location St. Louis, MO, USA
- Currency USD
- Founded November 2010
- Employees 5
- Website retectix.com
Company Summary
Retectix, LLC utilizes proprietary technology to produce nanofabricated surgical products for a variety of clinical applications. The initial offering in this line of products is the DuraStarTM Dural Substitute, a synthetic nanofabricated mesh for use in neurosurgical procedures. DuraStarTM provides superior handling properties, increased ease of use, improved biocompatibility, and reduced rates of complications compared to current products.
Team
-
Agnes Rey-GiraudCEO
Agnes recently retired from Express Scripts, Inc., where she served as President of International Operations. In her most recent role as President, International Operations, Agnes led the company’s movement into Asia. Agnès earned a Master of Science in Mechanical Engineering from Ecole Nationale d'Ingénieurs de Saint Etienne and an MBA from the University of Chicago.
-
Matthew MacEwanPresident / CSO
Matthew is an MD/PhD Candidate at Washington University School of Medicine in St. Louis, MO. Matthew has received multiple awards for his scientific and entrepreneurial work, including the 2012 Top 40 Under 40 in St. Louis (St. Louis Business Journal). Matthew graduated Summa Cum Laude with a degree in Biomedical Engineering from Case Western Reserve University in Cleveland, Ohio with a specialization in polymer biomaterials.
-
Rhonda SoestVP, Sales + Marketing
Rhonda is a clinician as well as a Marketing and Commercialization Executive who has successful leadership experience in Marketing, Operations, Business Development and Contract Negotiations. Rhonda has diverse product expertise in pharmaceutical, medical device and the biotechnology sectors. Prior to joining Retectix, LLC, Rhonda consistently delivered net sales and above target for OrthoBiotech, Inc., Johnson&Johnson, Inc., and Covidien, Inc.
-
Julie CochranDirector, Business Development
Julie served multiple roles in the biotechnology sector working at both McKinsey & Company, Inc., and Amgen, Inc. Julie earned a Bachelors of Science in Biomedical and Electrical Engineering at Duke University, and holds an MBA from the Stanford Graduate School of Business.
-
Tamas KovacsProject Manager
Interested in driving operational efficiency, Tamás spent the last 2 years in China as a project manager for a Fortune 100 company within the healthcare services industry. After obtaining a bachelor’s degree in Operations Research and Industrial Engineering, Tamás went on to receive a master’s in Engineering Management, both degrees from Cornell University.
Advisors
-
Polsinelli Shughart, Global Patent GroupLawyerUnconfirmedRubin BrownAccountantUnconfirmed
Previous Investors
-
Washington University in St. LouisUnconfirmedLicensing Executives Society (LES)UnconfirmedPrivate Investment Group in St. Louis, MOUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.